Close Menu
PNN DigitalPNN Digital
    Facebook X (Twitter) Instagram
    PNN DigitalPNN Digital
    • Business
    • National
    • Entertainment
    • Lifestyle
    • Education
    • Press Release
    • Submit Your PR
    PNN DigitalPNN Digital
    Home - Business - Intas launches the World’s First SB-100mg Itraconazole
    Business

    Intas launches the World’s First SB-100mg Itraconazole

    PNN Online DeskBy PNN Online DeskOctober 16, 2021No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    This medical breakthrough will significantly reduce cost and increase compliance in patients undergoing Antifungal Therapy

    Ahmedabad (Gujarat) [India], October 16: One of the world’s leading pharmaceutical companies, Intas Pharmaceuticals, has made a progressive breakthrough in the Antifungal Therapy domain with the launch of the world’s first Super Bioavailable Itraconazole-SB 100mg by the Brand Name of Itaspor-SB Forte/Subawin. It has been recently approved by Indian Regulatory Authorities.

    Conventional Itraconazole mainstay drug to fight fungal infection has high result variance and low patient compliance because of dosing dependence upon food, acidic beverage, antacids consumption etc. and overall cost of treatment.

    Itaspor SB Forte/Subawinis expected to improve patient compliance and reduce the Doctor’s counselling time. It will reduce dosing to half. Furthermore, patients can take it with or without a meal with just water or as directed by the physician. The cost of the therapy is also reduced substantially.

    As per published literature and clinicians’ experience, the Itraconazole molecule has low blood drug concentration, affecting safety and efficacy when taken orally. These blood levels highly vary from patient to patient. Moreover, the recommendation to take it with a full fatty meal and an acidic beverage further reduces patient compliance and adds to the problem of desired blood drug concentration. Another factor is the cost of therapy for fungal infection patients, as treatment duration varies from 3 to 8 weeks.

    “Intas’ newest formulation within the 25-year-old brand Itasporis formulated with Super Bioavailable (SB) Technology that makes 1 Itaspor-SB Forte capsule equivalent to conventional 200mg Itraconazole,” said Dr Alok Chaturvedi, Senior Vice-president & Head – Medical Affairs, Intas Pharmaceuticals.

    “Given the benefits of Super Bioavailable (SB) Technology like half the drug, no inter-patient variability, freedom to prescribe with/without food, any beverage, even with Antacids, and that too with a reduction in overall treatment cost certainly seems to be a win-win proposition.”, said Dr R D Kharkar, Senior Consultant Dermatologist, Mumbai.

    About Intas

    Intas Pharmaceuticals Ltd. is a leading, vertically integrated pharmaceutical company based in Ahmedabad, India, having end-to-end capabilities of formulation development, manufacturing and marketing along with backward integration of APIs. Intas has more than 18,000 employees, sells products in more than 85 countries and has 14 manufacturing sites worldwide. The Intas group’s revenues amounted to USD 2.1 bn in FY 2020, and the compounded annual growth rate of Intas’ revenues has exceeded 25% in the past 10 years.

    For more information, please visit https://www.intaspharma.com/

    Dr Alok Chaturvedi INTAS Pharma INTAS Intas Pharma
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    PNN Online Desk
    • Website

    Related Posts

    India Gears Up for the Indian Fashion Glamour League: Where Style Meets Strategy

    August 4, 2025

    1X Properties Unveils New Brand Identity and Launches Tech-Integrated Global Affiliate Program at High-Profile International Event

    August 4, 2025

    18 Mall Pre-Launch by Actor Jeeva, Priyadarshini Kumar & John Cris Terrence – East Coast’s Ultimate Food& Entertainment Destination

    August 4, 2025
    Add A Comment

    Comments are closed.

    Recent Posts
    • India Gears Up for the Indian Fashion Glamour League: Where Style Meets Strategy
    • 1X Properties Unveils New Brand Identity and Launches Tech-Integrated Global Affiliate Program at High-Profile International Event
    • 18 Mall Pre-Launch by Actor Jeeva, Priyadarshini Kumar & John Cris Terrence – East Coast’s Ultimate Food& Entertainment Destination
    • Driving Sustainability in Food Supply Chains: A Global Leader’s Journey from India to the U.S.
    • Wah! Puchka Wah! Litti Raises USD 230k from Wow Momo Founder Sagar Daryani, and other Global Angel Investors

    India Gears Up for the Indian Fashion Glamour League: Where Style Meets Strategy

    August 4, 2025

    1X Properties Unveils New Brand Identity and Launches Tech-Integrated Global Affiliate Program at High-Profile International Event

    August 4, 2025

    18 Mall Pre-Launch by Actor Jeeva, Priyadarshini Kumar & John Cris Terrence – East Coast’s Ultimate Food& Entertainment Destination

    August 4, 2025

    Driving Sustainability in Food Supply Chains: A Global Leader’s Journey from India to the U.S.

    August 4, 2025

    Wah! Puchka Wah! Litti Raises USD 230k from Wow Momo Founder Sagar Daryani, and other Global Angel Investors

    August 4, 2025

    GTF Technologies: The Agency That Quietly Reimagined Real Estate Marketing in India

    August 4, 2025
    PNN Digital
    2025 © pnn.digital

    Type above and press Enter to search. Press Esc to cancel.